Paid Clinical Trials Washington, D.C.

Discover 822 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 822

Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Washington, Baltimore, Frederick, Norfolkshow 42 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)

Recruiting

Sponsor:

Children's National Research Institute

Location:

Washington

Code:

NCT05310227

Conditions

New Daily Persistent Headache (NDPH)

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Nerivio

Prevalence and Level of Thienopyridine Resistance Seen in a Contemporary Percutaneous Coronary Intervention or Coronary Artery Bypass Graft Population

Recruiting

Sponsor:

Medstar Health Research Institute

Location:

Washington

Code:

NCT01408927

Conditions

Increased Drug Resistance

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Thienopyridine resistance testing

Aspirin resistance testing

Genetic polymorphism assessment

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Recruiting

PHASE1

Sponsor:

Pediatric Brain Tumor Consortium

Location:

Washington, Pittsburgh, New York, Buffaloshow 8 more

Code:

NCT04978727

Conditions

Medulloblastoma

Glioblastoma Multiforme

Anaplastic Astrocytoma

High-grade Astrocytoma NOS

Anaplastic Oligodendroglioma

Eligibility Criteria

Sex: All

Age: 1 - 21

Healthy Volunteers: Not accepted

Interventions

SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years

SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years

SurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years

K0706 for Patients Diagnosed With Dementia With Lewy Bodies

Recruiting

PHASE2

Sponsor:

Georgetown University

Location:

Washington

Code:

NCT03996460

Conditions

Dementia With Lewy Bodies

Eligibility Criteria

Sex: All

Age: 25 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

192 mg powder of K0706

384 mg powder of K0706

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Recruiting

Sponsor:

UCLA

Location:

Washington, Charlottesville, New York, New Havenshow 17 more

Code:

NCT05230173

Conditions

Ulcerative Colitis

Crohn Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pragmatic

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Takeda

Location:

Washington, New York, New Haven, Indianapolisshow 7 more

Code:

NCT04844073

Conditions

Squamous Cell Cancer of Head and Neck (SCCHN)

Non-small Cell Lung Cancer (NSCLC)

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAK-186

Efficacy of Atenativ in Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

Recruiting

PHASE3

Sponsor:

Octapharma

Location:

Washington, Peoria, Miami

Code:

NCT04918173

Conditions

Congenital Antithrombin Deficiency

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Atenativ

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Recruiting

PHASE1

Sponsor:

Allogene Therapeutics

Location:

Washington, New York, New Haven, Detroitshow 6 more

Code:

NCT04696731

Conditions

Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ALLO-316

ALLO-647

Fludarabine

Cyclophosphamide

A Prospective Longitudinal Study in Adults with Multifocal Motor Neuropathy

Recruiting

Sponsor:

argenx

Location:

Washington, Philadelphia, New Brunswick, Pittsburghshow 23 more

Code:

NCT05988073

Conditions

Multifocal Motor Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Comparing Two Methods to Follow Patients With Pancreatic Cysts

Recruiting

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Washington, Falls Church, Fairfax, Glen Burnieshow 224 more

Code:

NCT04239573

Conditions

Pancreatic Carcinoma

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Computed Tomography

Endoscopic Ultrasound

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration